共 21 条
[1]
Tomasetti M., Amati M., Santarelli L., Et al., Malignant mesothelioma: Biology, diagnosis and therapeutic approaches, Curr Mol Pharmacol, 2, pp. 190-206, (2009)
[2]
Paleari L., Rotolo N., Imperatori A., Et al., Osteopontin is not a specific marker in malignant pleural mesothelioma, Int J Biol Markers, 24, 2, pp. 112-117, (2009)
[3]
Belli C., Fennell D., Giovannini M., Et al., Malignant pleural mesothelioma: Current treatments and emerging drugs, Expert Opin Emerg Drugs, 14, 3, pp. 423-437, (2009)
[4]
Neragi-Miandoab S., Multimodality approach in management of malignant pleural mesothelioma, European Journal of Cardio-thoracic Surgery, 29, 1, pp. 14-19, (2006)
[5]
Shukla A., Bosenberg M.W., MacPherson M.B., Et al., Activated cAMP response element binding protein is overexpressed in human mesotheliomas and inhibits apoptosis, Am J Pathol, 175, 5, pp. 2197-2206, (2009)
[6]
Kothmaier H., Quehenberger F., Halbwedl I., Morbini P., Demirag F., Zeren H., Comin C.E., Murer B., Cagle P.T., Attanoos R., Gibbs A.R., Galateau-Salle F., Popper H.H., EGFR and PDGFR differentially promote growth in malignant epithelioid mesothelioma of short and long term survivors, Thorax, 63, 4, pp. 345-351, (2008)
[7]
Rawlings J.S., Rosler K.M., Harrison D.A., The JAK/STAT signaling pathway, Journal of Cell Science, 117, 8, pp. 1281-1283, (2004)
[8]
Mattick J.S., Challenging the dogma: The hidden layer of non-protein-coding RNAs in complex organisms, BioEssays, 25, 10, pp. 930-939, (2003)
[9]
Gregory R.I., Yan K.-P., Amuthan G., Chendrimada T., Doratotaj B., Cooch N., Shiekhattar R., The Microprocessor complex mediates the genesis of microRNAs, Nature, 432, 7014, pp. 235-240, (2004)
[10]
Meola N., Gennarino V.A., Banfi S., MicroRNAs and genetic diseases, Pathogenetics, 2, 1, (2009)